Polymorphisms in phase i-metabolising enzyme and hormone receptor genes influence the response to anti-tnf therapy

L. M. Canet, J. M. Sanchez-Maldonado, A. Rodriguez-Ramos, C. B. Lupianez, H. Canhao, M. Martinez-Bueno, A. Escudero, J. Segura-Catena, S. B. Sorensen, M. L. Hetland, M. J. Soto-Pino, M. A. Ferrer, A. Garcia, B. Glintborg, I. Filipescu, E. Perez-Pampin, A. Gonzalez-Utrilla, M. A. Lopez-Nevot, P. Conesa-Zamora, A. A. den BroederS. da Vita, S. E. Hove Jacobsen, E. Collantes, L. Quartuccio, J. E. Fonseca, M. J. Coenen, V. Andersen, R. Caliz-Caliz, J. Sainz

Research output: Contribution to journalMeeting Abstract

Original languageEnglish
Pages (from-to)234-235
JournalAnnals of the rheumatic diseases
Volume77
DOIs
Publication statusPublished - Jun 2018

Cite this